Work

Phase I–II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas

Year: 2005

Type: article

Study design: Clinical Trial

Source: Gene Therapy

DOI: 10.1038/sj.gt.3302436

Authors: E Galanis, S H Okuno, A G Nascimento, B D Lewis, R A Lee, A M Oliveira, J A Sloan, P Atherton, J H Edmonson, C Erlichman, B Randlev, Q Wang, S Freeman, J Rubin

Institution: Mayo Clinic

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Mayo Clinic, National Cancer Institute, NIH Clinical Center

Awards: G1237584944, FUSOGENIC MEMBRANE PROTEINS AS THERAPEUTIC TRANSGENES, Phase I Clinical Trials of Anticancer Agents

OpenAlex ID: W1985842299

FWCI: 8.486

Cites: 29

Cited by: 173

Related to: 10